Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fritz Diekmann

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
Immunosuppressive minimization with mTOR inhibitors and belataceptFritz Diekmann
Transplantation Research|June 14, 2016
Practical considerations for the use of mTOR inhibitorsFritz Diekmann, Josep M Campistol
Transplantation Reviews (Orlando, Fla.)|December 6, 2011
mTOR inhibitor-associated proteinuria in kidney transplant recipientsFritz Diekmann, Amado Andrés, Federico Oppenheimer
Transplantation Direct|September 8, 2025
Exploring the Role of Extracorporeal Photopheresis in Kidney Transplant ManagementMichael Nicoli, Jordi Rovira, Fritz Diekmann
International Journal of Molecular Sciences|July 27, 2022
Medical Aspects of mTOR Inhibition in Kidney TransplantationElena Cuadrado-Payán, Fritz Diekmann, David Cucchiari
Expert Opinion on Drug Safety|December 16, 2015
Safety of mTOR inhibitors in adult solid organ transplantationPedro Ventura-Aguiar, Josep Maria Campistol, Fritz Diekmann
Transfusion|July 19, 2012
Haptoglobin is present in albumin used as a replacement solution for plasma exchangeJoan Cid, Montserrat Elena, Fritz Diekmann, et al.
Frontiers in Immunology|June 7, 2024
The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical needJean-François Augusto, Christian Benden, Fritz Diekmann, et al.
Kidney & Blood Pressure Research|July 17, 2004
Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patientsFritz Diekmann, Lutz Fritsche, Hans-Hellmut Neumayer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 3, 2017
Death of recipients after kidney living donation triples donors' risk of dropping out from follow-up: a retrospective studyXavier Torres, Jordi Comas, Emma Arcos, et al.
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
Immunosuppressive minimization with mTOR inhibitors and belataceptFritz Diekmann
Transplantation Research|June 14, 2016
Practical considerations for the use of mTOR inhibitorsFritz Diekmann, Josep M Campistol
Transplantation Reviews (Orlando, Fla.)|December 6, 2011
mTOR inhibitor-associated proteinuria in kidney transplant recipientsFritz Diekmann, Amado Andrés, Federico Oppenheimer
Transplantation Direct|September 8, 2025
Exploring the Role of Extracorporeal Photopheresis in Kidney Transplant ManagementMichael Nicoli, Jordi Rovira, Fritz Diekmann
International Journal of Molecular Sciences|July 27, 2022
Medical Aspects of mTOR Inhibition in Kidney TransplantationElena Cuadrado-Payán, Fritz Diekmann, David Cucchiari
Expert Opinion on Drug Safety|December 16, 2015
Safety of mTOR inhibitors in adult solid organ transplantationPedro Ventura-Aguiar, Josep Maria Campistol, Fritz Diekmann
Transfusion|July 19, 2012
Haptoglobin is present in albumin used as a replacement solution for plasma exchangeJoan Cid, Montserrat Elena, Fritz Diekmann, et al.
Frontiers in Immunology|June 7, 2024
The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical needJean-François Augusto, Christian Benden, Fritz Diekmann, et al.
Kidney & Blood Pressure Research|July 17, 2004
Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patientsFritz Diekmann, Lutz Fritsche, Hans-Hellmut Neumayer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 3, 2017
Death of recipients after kidney living donation triples donors' risk of dropping out from follow-up: a retrospective studyXavier Torres, Jordi Comas, Emma Arcos, et al.
Pageof 19